previous | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | next
| CSGID ID | Priority | Locus Tag | NCBI GI | Gene Name |
Common Name | Sequence Length |
Comment | Project | Homolog PDB ID |
Homolog Sequence Identity |
Target Organism | TIGR Main Role | TIGR Subrole | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IDP01189 | 1 | BA_0505 | 30254033 | glycosyl transferase, group 2 family pro... | 528 | Drug Target Function | March 2008 | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||||
| IDP01190 | 1 | BA_0872 | 30254622 | N-acetylmuramoyl-L-alanine amidase, fami... | 348 | Drug Target Function | March 2008 | 1YB0 | 16.7% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP01191 | 1 | BA_0882 | 81837776 | Protein translocase subunit secA 2 | 788 | Conserved Gene / Pathway | March 2008 | 1M6N | 48% | Bacillus anthracis | Protein fate | Protein and peptide secretion and trafficking | ||||||||||||||||||
| IDP01192 | 1 | BA_1184 | 34098435 | 3-oxoacyl-[acyl-carrier-protein] synthas... | 310 | Drug Target Function | March 2008 | 1EBL | 61.6% | Bacillus anthracis | Fatty acid and phospholipid metabolism | Biosynthesis | ||||||||||||||||||
| IDP01193 | 1 | BA_1185 | 30254899 | fabF | 3-oxoacyl-(acyl-carrier-protein) synthas... | 412 | Drug Target Function | March 2008 | 1B3N | 64.8% | Bacillus anthracis | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP01194 | 1 | BA_1230 | 30255179 | rfbB | dTDP-glucose 4,6-dehydratase | 322 | Conserved Gene / Pathway | March 2008 | 1A9Y | 51.9% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | |||||||||||||||||
| IDP01195 | 1 | BA_1231 | 30255180 | rfbD | dTDP-4-dehydrorhamnose reductase | 284 | Drug Target Function | March 2008 | 1KBZ | 46.1% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | |||||||||||||||||
| IDP01196 | 1 | BA_1248 | 30255197 | trpE | anthranilate synthase component I | 471 | Drug Target Function | March 2008 | 1I1Q | 38.4% | Bacillus anthracis | Amino acid biosynthesis | Aromatic amino acid family | |||||||||||||||||
| IDP01197 | 1 | BA_1389 | 81715334 | D-alanine--poly(phosphoribitol) ligase s... | 503 | Conserved Gene / Pathway | March 2008 | 1AMU | 56.7% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP01198 | 1 | BA_1518 | 59798071 | Cytidylate kinase (CK) (Cytidine monopho... | 225 | Conserved Gene / Pathway | March 2008 | 1CKE | 53.8% | Bacillus anthracis | Purines, pyrimidines, nucleosides, and nucleotides | Nucleotide and nucleoside interconversions | ||||||||||||||||||
| IDP01199 | 1 | BA_1537 | 67460530 | Chorismate synthase 1 (5-enolpyruvylshik... | 390 | Drug Target Function | March 2008 | 1Q1L | 59% | Bacillus anthracis | Amino acid biosynthesis | Aromatic amino acid family | ||||||||||||||||||
| IDP01200 | 1 | BA_1707 | 30255995 | transglycosylase, SLT family | 261 | Drug Target Function | March 2008 | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||||
| IDP01201 | 1 | BA_1826 | 34098434 | 3-oxoacyl-[acyl-carrier-protein] synthas... | 327 | Drug Target Function | March 2008 | 1BI5 | 40.7% | Bacillus anthracis | Fatty acid and phospholipid metabolism | Biosynthesis | ||||||||||||||||||
| IDP01202 | 1 | BA_2079 | 30256728 | dal-2 | alanine racemase | 391 | Drug Target Function | March 2008 | 1BD0 | 40.2% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01203 | 1 | BA_2083 | 30256732 | glycosyltransferase, MGT family | 402 | Conserved Gene / Pathway | March 2008 | 2ACV | 27.6% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP01204 | 1 | BA_2274 | 30256914 | glycosyl transferase, group 2 family pro... | 406 | Essential Gene | March 2008 | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||||
| IDP01205 | 1 | BA_2369 | 30257005 | dhbC | isochorismate synthase DhbC | 399 | Drug Target Function | March 2008 | 1I1Q | 23.3% | Bacillus anthracis | Biosynthesis of cofactors, prosthetic groups, and carriers | Other | |||||||||||||||||
| IDP01206 | 1 | BA_2446 | 30257076 | N-acetylmuramoyl-L-alanine amidase, fami... | 245 | Conserved Gene / Pathway | March 2008 | 1XOV | 26.5% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP01207 | 1 | BA_2610 | 39930865 | D-alanine--D-alanine ligase (D-alanylala... | 304 | Conserved Gene / Pathway | March 2008 | 1A9X | 37.2% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01208 | 1 | BA_2638 | 30257255 | glycosyl transferase, putative | 387 | Essential Gene | March 2008 | 2IYA | 27.6% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP01209 | 1 | BA_2650 | 30257267 | penicillin-binding protein | 340 | Drug Target Function | March 2008 | 1C3B | 27.1% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01210 | 1 | BA_2805 | 30257409 | glycosyl hydrolase, family 25, putative ... | 268 | Conserved Gene / Pathway | March 2008 | 2NW0 | 51.9% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP01211 | 1 | BA_2958 | 30257549 | chorismate mutase/phospho-2-dehydro-3-de... | 358 | Drug Target Function | March 2008 | 1D9E | 39.1% | Bacillus anthracis | Amino acid biosynthesis | Aromatic amino acid family | ||||||||||||||||||
| IDP01212 | 1 | BA_3024 | 30257611 | glycosyl transferase, group 2 family pro... | 490 | Essential Gene | March 2008 | 3CKJ | 8.6% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP01213 | 1 | BA_3251 | 30257808 | 3-oxoacyl-(acyl-carrier-protein) synthas... | 329 | Drug Target Function | March 2008 | 1BI5 | 34.7% | Bacillus anthracis | Fatty acid and phospholipid metabolism | Biosynthesis | ||||||||||||||||||
| IDP01214 | 1 | BA_3460 | 30257999 | cfa | cyclopropane-fatty-acyl-phospholipid syn... | 390 | Drug Target Function | March 2008 | 1DUS | 25.1% | Bacillus anthracis | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP01215 | 1 | BA_3506 | 30258044 | penicillin-binding protein, putative | 345 | Drug Target Function | March 2008 | 1CEF | 25.5% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01216 | 1 | BA_3577 | 30258105 | glycosyl transferase, group 1 family pro... | 270 | Essential Gene | March 2008 | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||||
| IDP01217 | 1 | BA_3695 | 30258216 | S-layer protein, putative | 510 | Drug Target Function | March 2008 | Bacillus anthracis | Cell envelope | Surface structures | ||||||||||||||||||||
| IDP01218 | 1 | BA_3712 | 73919984 | Histidine ammonia-lyase (Histidase) | 505 | Drug Target Function | March 2008 | 1B8F | 42.2% | Bacillus anthracis | Energy metabolism | Amino acids and amines | ||||||||||||||||||
| IDP01219 | 1 | BA_3767 | 30258283 | prophage LambdaBa01, N-acetylmuramoyl-L-... | 310 | Drug Target Function | March 2008 | 1YB0 | 39% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP01220 | 1 | BA_3983 | 30258492 | ffH | signal recognition particle protein | 449 | Conserved Gene / Pathway | March 2008 | 1DUL | 51.7% | Bacillus anthracis | Protein fate | Protein and peptide secretion and trafficking | |||||||||||||||||
| IDP01221 | 1 | BA_3990 | 30258499 | fabD | malonyl CoA-acyl carrier protein transac... | 314 | Drug Target Function | March 2008 | 1MLA | 44.9% | Bacillus anthracis | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP01222 | 1 | BA_4049 | 33301352 | UDP-N-acetylglucosamine--N-acetylmuramyl... | 364 | Drug Target Function | March 2008 | 1F0K | 31.6% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01223 | 1 | BA_4051 | 60390084 | UDP-N-acetylmuramoylalanine--D-glutamate... | 450 | Conserved Gene / Pathway | March 2008 | 1E0D | 34.4% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01224 | 1 | BA_4054 | 30258561 | sporulation specific penicillin-binding ... | 638 | Drug Target Function | March 2008 | 1K25 | 26.6% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01225 | 1 | BA_4139 | 61211625 | Phosphopantetheine adenylyltransferase (... | 163 | Drug Target Function | March 2008 | 1B6T | 71.2% | Bacillus anthracis | Biosynthesis of cofactors, prosthetic groups, and carriers | Pantothenate and coenzyme A | ||||||||||||||||||
| IDP01226 | 1 | BA_4187 | 39931064 | Peptide deformylase 2 (PDF 2) (Polypepti... | 184 | Drug Target Function | March 2008 | 1BS4 | 96.2% | Bacillus anthracis | Protein fate | Protein modification and repair | ||||||||||||||||||
| IDP01227 | 1 | BA_4268 | 30258770 | ptsH-1 | phosphocarrier protein HPr | 87 | Conserved Gene / Pathway | March 2008 | 1CM2 | 72.4% | Bacillus anthracis | Transport and binding proteins | Carbohydrates, organic alcohols, and acids | |||||||||||||||||
| IDP01228 | 1 | BA_4283 | 30258785 | peptidyl-prolyl cis-trans isomerase, cyc... | 145 | Conserved Gene / Pathway | March 2008 | 1A33 | 42.1% | Bacillus anthracis | Protein fate | Protein folding and stabilization | ||||||||||||||||||
| IDP01229 | 1 | BA_4540 | 52782922 | Protein grpE (HSP-70 cofactor) | 188 | Conserved Gene / Pathway | March 2008 | 1DKG | 35.1% | Bacillus anthracis | Protein fate | Protein folding and stabilization | ||||||||||||||||||
| IDP01230 | 1 | BA_4638 | 33300883 | Adenine phosphoribosyltransferase (APRT)... | 170 | Drug Target Function | March 2008 | 1G2P | 52.4% | Bacillus anthracis | Purines, pyrimidines, nucleosides, and nucleotides | Salvage of nucleosides and nucleotides | ||||||||||||||||||
| IDP01231 | 1 | BA_4684 | 30259179 | mreB | rod shape-determining protein MreB | 339 | Drug Target Function | March 2008 | 1JCE | 52.2% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01232 | 1 | BA_5112 | 30259596 | menF | menaquinone-specific isochorismate synth... | 464 | Drug Target Function | March 2008 | 1I1Q | 21.3% | Bacillus anthracis | Biosynthesis of cofactors, prosthetic groups, and carriers | Menaquinone and ubiquinone | |||||||||||||||||
| IDP01233 | 1 | BA_5335 | 30259811 | estA | carboxylesterase | 246 | Drug Target Function | March 2008 | 1R1D | 79.3% | Bacillus anthracis | Cellular processes | Detoxification | |||||||||||||||||
| IDP01234 | 1 | BA_5509 | 30259969 | UDP-N-acetylglucosamine 2-epimerase | 371 | Drug Target Function | March 2008 | 1F6D | 100% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP01235 | 1 | BA_5512 | 30259972 | wecC | UDP-N-acetyl-D-mannosamine dehydrogenase... | 427 | Drug Target Function | March 2008 | 1DLI | 28.6% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | |||||||||||||||||
| IDP01236 | 1 | BA_5514 | 30259974 | glycosyl transferase, group 1 family pro... | 550 | Drug Target Function | March 2008 | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||||
| IDP01237 | 1 | BA_5563 | 46396830 | Glucose-specific phosphotransferase enzy... | 165 | Drug Target Function | March 2008 | 1AX3 | 46.7% | Bacillus anthracis | Transport and binding proteins | Carbohydrates, organic alcohols, and acids | ||||||||||||||||||
| IDP01238 | 1 | BA_5635 | 30260086 | lipoate-protein ligase A, putative | 281 | Drug Target Function | March 2008 | 2P0L | 60.1% | Bacillus anthracis | Protein fate | Protein modification and repair | ||||||||||||||||||
| IDP01239 | 1 | BA_5670 | 30260118 | glycosyl transferase, group 1 family pro... | 366 | Drug Target Function | March 2008 | 2BFW | 26.2% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP01240 | 1 | BA_1069 | 30254800 | pbpF | penicillin-binding protein 1 | 705 | Drug Target Function | March 2008 | 2BG1 | 27.4% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01241 | 1 | BA_1474 | 30255405 | penicillin-binding protein | 673 | Drug Target Function | March 2008 | 2BG1 | 28.8% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01242 | 1 | BA_1572 | 30255873 | penicillin-binding protein | 897 | Drug Target Function | March 2008 | 1FNF | 27.9% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01243 | 1 | BA_2345 | 30256982 | penicillin-binding protein 1A | 820 | Drug Target Function | March 2008 | 1MWR | 29.5% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01244 | 1 | BA_2504 | 30257132 | penicillin-binding protein | 588 | Drug Target Function | March 2008 | 1MWR | 23.6% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01245 | 1 | BA_2637 | 30257254 | penicillin-binding protein | 708 | Drug Target Function | March 2008 | 1MWR | 21% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01246 | 1 | BA_2648 | 30257265 | penicillin-binding protein | 712 | Drug Target Function | March 2008 | 1K25 | 29.9% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01247 | 1 | BA_3214 | 30257780 | penicillin-binding protein, putative | 691 | Drug Target Function | March 2008 | 1BLS | 14.2% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01248 | 1 | BA_3554 | 30258085 | penicillin-binding protein, putative | 377 | Drug Target Function | March 2008 | 1BLS | 22.3% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01249 | 1 | BA_4055 | 30258562 | penicillin-binding protein | 716 | Drug Target Function | March 2008 | 1K25 | 30.7% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01250 | 1 | BA_4497 | 30259003 | penicillin-binding protein | 706 | Drug Target Function | March 2008 | 2Z2L | 14.6% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01251 | 1 | BA_4606 | 30259106 | penicillin-binding protein | 584 | Drug Target Function | March 2008 | 1MWR | 22.9% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01252 | 1 | BA_5623 | 30260075 | penicillin-binding protein | 683 | Drug Target Function | March 2008 | 2BG1 | 27.5% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01253 | 1 | BA_2575 | 30257197 | penicillin-binding protein, putative | 481 | Drug Target Function | March 2008 | 1BLS | 20% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01254 | 1 | BA_1228 | 30255177 | glucose-1-phosphate thymidylyltransferas... | 245 | Conserved Gene / Pathway | March 2008 | 1FXO | 46.1% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP01255 | 1 | BA_5132 | 30259616 | yugI | general stress protein 13 | 114 | Conserved Gene / Pathway | March 2008 | 1Q8K | 34.2% | Bacillus anthracis | Cellular processes | Adaptations to atypical conditions | |||||||||||||||||
| IDP01256 | 1 | BA_1232 | 30255181 | fabI | enoyl-(acyl-carrier-protein) reductase | 256 | Drug Target Function | March 2008 | 1AE1 | 100% | Bacillus anthracis | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP01257 | 1 | BA_5677 | 30260125 | glycosyl transferase, group 2 family pro... | 267 | Drug Target Function | March 2008 | 3BCV | 11.2% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP01258 | 1 | BA_2238 | 30256883 | pbpC | penicillin-binding protein 3 | 661 | Drug Target Function | March 2008 | 1K25 | 34.9% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01300 | 1 | VC2165 | 15642164 | arsenate reductase | 116 | Conserved Gene / Pathway | March 2008 | 1I9D | 44.8% | Vibrio cholerae | Cellular processes | Detoxification | ||||||||||||||||||
| IDP01301 | 1 | VC0170 | 15640200 | peptide ABC transporter, ATP-binding pro... | 571 | Conserved Gene / Pathway | March 2008 | 1B0U | 22.4% | Vibrio cholerae | Transport and binding proteins | Amino acids, peptides and amines | ||||||||||||||||||
| IDP01302 | 1 | VC0263 | 15640292 | galactosyl-transferase, putative | 184 | Conserved Gene / Pathway | March 2008 | Vibrio cholerae | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||||
| IDP01303 | 1 | VC0573 | 15640595 | ubiquinol--cytochrome c reductase, iron-... | 197 | Conserved Gene / Pathway | March 2008 | 1BCC | 38.1% | Vibrio cholerae | Energy metabolism | Electron transport | ||||||||||||||||||
| IDP01304 | ||||||||||||||||||||||||||||||